CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 54 filers reported holding CORVUS PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $7,000 | -12.5% | 2,059 | 0.0% | 0.00% | – |
| Q1 2019 | $8,000 | 0.0% | 2,059 | 0.0% | 0.00% | – |
| Q4 2018 | $8,000 | -55.6% | 2,059 | 0.0% | 0.00% | – |
| Q3 2018 | $18,000 | -21.7% | 2,059 | 0.0% | 0.00% | – |
| Q2 2018 | $23,000 | +64.3% | 2,059 | +72.3% | 0.00% | – |
| Q1 2018 | $14,000 | +16.7% | 1,195 | 0.0% | 0.00% | – |
| Q4 2017 | $12,000 | -63.6% | 1,195 | -41.6% | 0.00% | – |
| Q3 2017 | $33,000 | +266.7% | 2,046 | +171.4% | 0.00% | – |
| Q2 2017 | $9,000 | -43.8% | 754 | 0.0% | 0.00% | – |
| Q1 2017 | $16,000 | +45.5% | 754 | 0.0% | 0.00% | – |
| Q4 2016 | $11,000 | – | 754 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 3,749,379 | $18,147,000 | 3.77% |
| VR Adviser, LLC | 3,427,461 | $16,589,000 | 2.13% |
| ADAMS STREET PARTNERS LLC | 3,275,616 | $15,854,000 | 2.04% |
| Telemetry Investments, L.L.C. | 196,168 | $949,000 | 1.28% |
| DC Investments Management, LLC | 50,709 | $245,000 | 0.46% |
| Orbimed Advisors | 6,943,654 | $33,607,000 | 0.37% |
| EcoR1 Capital, LLC | 2,081,077 | $10,072,000 | 0.35% |
| BVF INC/IL | 1,370,947 | $6,635,000 | 0.26% |
| Ikarian Capital, LLC | 757,545 | $3,666,000 | 0.26% |
| CHI Advisors LLC | 165,927 | $803,000 | 0.23% |